VERU INC. Increase (Decrease) in Accounts Receivable
VERU INC. (VERU) reported Increase (Decrease) in Accounts Receivable of $0 for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-10
- VERU INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $0.00.
- VERU INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $0.00.
- VERU INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- VERU INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- VERU INC. increase (decrease) in accounts receivable for fiscal 2025 was $657.25K.
- VERU INC. increase (decrease) in accounts receivable for fiscal 2024 was -$546.20K, a 113.15% decline from fiscal 2023.
- VERU INC. increase (decrease) in accounts receivable for fiscal 2023 was $4.15M.
- VERU INC. increase (decrease) in accounts receivable for fiscal 2022 was -$4.54M, a 227.40% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $657.25K 10-K · filed 2025-12-17 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $657.25K 10-Q · filed 2026-08-10 | $2.98M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $657.25K 10-Q · filed 2026-05-13 | $2.98M derived: sum of 3 quarters · filed 2026-05-13 | $1.83M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $657.25K 10-Q · filed 2026-02-11 | $2.98M derived: sum of 2 quarters · filed 2026-02-11 | $1.83M derived: sum of 3 quarters · filed 2026-02-11 | $2.23M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-09-30 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $1.17M derived: sum of 2 quarters · filed 2025-12-17 | $1.58M derived: sum of 3 quarters · filed 2025-12-17 | -$546.20K 10-K · filed 2025-12-17 | ||||
| 2024-06-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -$740.87K derived: sum of 2 quarters · filed 2025-08-12 | -$2.86M 10-Q · filed 2025-08-12 | -$3.44M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $402.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-08 | -$1.72M 10-Q · filed 2025-05-08 | -$2.30M derived: sum of 3 quarters · filed 2025-05-08 | -$1.42M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$2.12M 10-Q · filed 2025-02-13 | -$2.70M derived: sum of 2 quarters · filed 2025-02-13 | -$1.82M derived: sum of 3 quarters · filed 2025-02-13 | $2.43M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-09-30 | -$576.37K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | $300.54K derived: sum of 2 quarters · filed 2024-12-16 | $4.55M derived: sum of 3 quarters · filed 2024-12-16 | $4.15M 10-K · filed 2024-12-16 | ||||
| 2023-06-30 | $876.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | $5.13M derived: sum of 2 quarters · filed 2024-08-08 | $4.73M 10-Q · filed 2024-08-08 | -$738.15K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $4.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $3.85M 10-Q · filed 2024-05-08 | -$1.62M derived: sum of 3 quarters · filed 2024-05-08 | -$1.45M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$400.58K 10-Q · filed 2024-04-01 | -$5.87M derived: sum of 2 quarters · filed 2024-04-01 | -$5.70M derived: sum of 3 quarters · filed 2024-04-01 | -$4.21M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-09-30 | -$5.47M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | -$5.30M derived: sum of 2 quarters · filed 2024-04-01 | -$3.81M derived: sum of 3 quarters · filed 2024-04-01 | -$4.54M 10-K/A · filed 2024-04-01 | ||||
| 2022-06-30 | $165.56K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-11-15 | $1.65M derived: sum of 2 quarters · filed 2023-11-15 | $930.02K 10-Q/A · filed 2023-11-15 | $1.41M derived: sum of 4 quarters · filed 2023-11-15 | ||||
| 2022-03-31 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | $764.47K 10-Q · filed 2023-05-11 | $1.24M derived: sum of 3 quarters · filed 2023-05-11 | $4.41M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$724.68K 10-Q · filed 2023-02-09 | -$246.00K derived: sum of 2 quarters · filed 2023-02-09 | $2.92M derived: sum of 3 quarters · filed 2023-02-09 | $3.91M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-09-30 | $478.68K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $3.64M derived: sum of 2 quarters · filed 2022-12-05 | $4.63M derived: sum of 3 quarters · filed 2022-12-05 | $3.56M 10-K · filed 2022-12-05 | ||||
| 2021-06-30 | $3.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $4.15M derived: sum of 2 quarters · filed 2022-08-11 | $3.08M 10-Q · filed 2022-08-11 | $3.37M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $992.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$79.08K 10-Q · filed 2022-05-12 | $203.18K derived: sum of 3 quarters · filed 2022-05-12 | -$1.83M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$1.07M 10-Q · filed 2022-02-09 | -$789.18K derived: sum of 2 quarters · filed 2022-02-09 | -$2.82M derived: sum of 3 quarters · filed 2022-02-09 | -$1.63M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-09-30 | $282.26K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | -$1.75M derived: sum of 2 quarters · filed 2021-12-02 | -$554.97K derived: sum of 3 quarters · filed 2021-12-02 | $87.79K 10-K · filed 2021-12-02 | ||||
| 2020-06-30 | -$2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | -$837.24K derived: sum of 2 quarters · filed 2021-08-12 | -$194.47K 10-Q · filed 2021-08-12 | $365.97K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-12 | $1.84M 10-Q · filed 2021-05-12 | $2.40M derived: sum of 3 quarters · filed 2021-05-12 | $3.13M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $642.76K 10-Q · filed 2021-02-10 | $1.20M derived: sum of 2 quarters · filed 2021-02-10 | $1.94M derived: sum of 3 quarters · filed 2021-02-10 | $3.48M derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-09-30 | $560.44K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | $1.30M derived: sum of 2 quarters · filed 2020-12-10 | $2.84M derived: sum of 3 quarters · filed 2020-12-10 | $1.35M 10-K · filed 2020-12-10 | ||||
| 2019-06-30 | $736.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | $2.28M derived: sum of 2 quarters · filed 2020-08-13 | $791.27K 10-Q · filed 2020-08-13 | $1.26M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | $54.60K 10-Q · filed 2020-05-13 | $520.00K derived: sum of 3 quarters · filed 2020-05-13 | $1.43M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | -$1.49M 10-Q · filed 2020-02-12 | -$1.02M derived: sum of 2 quarters · filed 2020-02-12 | -$109.43K derived: sum of 3 quarters · filed 2020-02-12 | -$111.46K derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-09-30 | $465.39K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $1.38M derived: sum of 2 quarters · filed 2019-12-12 | $1.37M derived: sum of 3 quarters · filed 2019-12-12 | -$1.87M 10-K · filed 2019-12-12 | ||||
| 2018-06-30 | $910.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | $908.68K derived: sum of 2 quarters · filed 2019-08-08 | -$2.34M 10-Q · filed 2019-08-08 | -$2.33M 10-Q · filed 2018-08-14 | -$4.60M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | -$2.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$3.25M 10-Q · filed 2019-05-15 | -$3.26M 10-Q · filed 2018-05-11 | -$5.51M derived: sum of 3 quarters · filed 2019-05-15 | -$7.06M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | -$3.25M 10-Q · filed 2019-02-13 | -$3.23M 10-Q · filed 2018-02-14 | -$5.50M derived: sum of 2 quarters · filed 2019-02-13 | -$7.05M derived: sum of 3 quarters · filed 2019-02-13 | -$8.13M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-09-30 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | -$3.81M derived: sum of 2 quarters · filed 2018-12-13 | -$4.89M derived: sum of 3 quarters · filed 2018-12-13 | -$7.28M 10-K · filed 2018-12-13 | -$7.23M 10-K · filed 2018-01-02 | |||
| 2017-06-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | -$2.63M derived: sum of 2 quarters · filed 2018-08-14 | -$5.02M 10-Q · filed 2018-08-14 | -$5.05M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | -$3.47M 10-Q · filed 2018-05-11 | -$3.50M derived: sum of 3 quarters · filed 2018-05-11 | -$3.43M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | -$2.39M 10-Q · filed 2018-02-14 | -$2.42M derived: sum of 2 quarters · filed 2018-02-14 | -$2.35M derived: sum of 3 quarters · filed 2018-02-14 | -$1.46M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-09-30 | -$23.94K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $42.04K derived: sum of 2 quarters · filed 2018-01-02 | $927.88K derived: sum of 3 quarters · filed 2018-01-02 | $4.52M 10-K · filed 2018-01-02 | ||||
| 2016-06-30 | $65.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $951.82K derived: sum of 2 quarters · filed 2017-08-09 | $4.55M 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | $885.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $4.48M 10-Q · filed 2017-05-10 | ||||||
| 2015-12-31 | $3.60M 10-Q · filed 2017-02-09 | |||||||
| 2015-09-30 | $11.14M 10-K · filed 2018-01-02 | |||||||
| 2014-09-30 | $619.75K 10-K · filed 2016-12-12 | |||||||
| 2013-09-30 | -$4.90M 10-K · filed 2015-12-02 | |||||||
| 2012-09-30 | $5.01M 10-K · filed 2014-12-02 | |||||||
| 2011-09-30 | -$2.15M 10-K · filed 2013-12-03 | |||||||
| 2010-09-30 | -$3.35M 10-K · filed 2012-12-04 | |||||||
| 2009-09-30 | $1.29M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |